What Debra Travers really wanted to be was a marine biologist, until I found out Jacques Cousteau wasnt hiring.
How she wound up as chief executive of PolyAurum LLC, a Philadelphia start-up developing biodegradable gold nanoparticles for treating cancerous tumors, involved a professional journey of more than 30 years in pharmaceutical and diagnostics industries, and a personal battle with the disease shes now in business to defeat.
After determining that studying sea creatures was not a viable career choice, Travers a military kid from all over switched her major at Cedar Crest College in Allentown to medical technology. She graduated in 1979, then worked for three years in a hospital laboratory until she concluded she didnt like shift work and could do more.
What followed was an impressive career progression: Travers started as a chemistry technician at DuPont Biomedical Products Division, advancing to executive positions in marketing and product development at Centocor, GlaxoSmithKline, Endo Pharmaceuticals, and IMS Health.
Much of that work involved bringing new products through the long development and regulation-heavy process from concept to launch, with experience in therapeutic areas including oncology, urology, pain medicine, cardiology, and rheumatology. In an industry of specialty silos, Travers developed a uniquely blended expertise in marketing and R&D.
It was on March 23, 2006, that her health-care vocation turned personal: Travers, then a 50-year-old mother of two, was diagnosed with breast cancer.
An oncologist recommended a double mastectomy, removal of both ovaries, and chemotherapy. The tearful pleadings of her daughter, Kelly, then 18 I need you here when I graduate college, when I get married, when I have kids persuaded Travers to follow that recommendation.
She returned to work at Endo for seven more years, as a director in project management, before being laid off in June 2013, one month before her daughters wedding. The break gave Travers time to concentrate on the big event and to start to think what Id like to do when I grow up.
That process would lead her in late 2015 to PolyAurum, a start-up spun out of the University of Pennsylvania.
I became a CEO and a grandmother in the same year, said Travers, now 61, chuckling during a recent interview at the Pennovation Center incubator in West Philadelphia. From there, her home in Delaware, and the sites of pitch opportunities with investors, she is working to raise $1.3 million in seed funding by early in the fourth quarter, to help get PolyAurum closer to clinical trials on humans.
So far, research and testing funded through $4 million in grants to the university has been limited to mice with tumors. It has shown that gold nanocrystals greatly enhance the effectiveness of radiation on tumors without increasing harm to healthy surrounding tissue, said Jay Dorsey, an associate professor and radiation oncologist at Penn and one of four university faculty who developed the technology.
The effectiveness of metals in improving a tumors ability to absorb radiation has long been known, Dorsey said. But one of the stumbling blocks to incorporating gold nanoparticles in such therapeutics is that the metal is not eliminated from the body well, posing serious problems to vital organs such as the liver and spleen.
Penns David Cormode, a professor of radiology, and Andrew Tsourkas, a professor of bioengineering, have worked to make gold more biocompatible, resulting in PolyAurums current technology, Dorsey said. The gold nanocrystals are contained in a biodegradable polymer that allows enough metal to collect in a tumor. The polymer then breaks down, releasing the gold for excretion from the body so that it does not build up in key organs.
The companys name is a combination of those two essential ingredients: Poly, derived from polymer, and Aurum, the Latin word for gold.
Explaining all that, and the potential that PolyAurums founders see for extending and saving lives, is the message Travers now is in charge of disseminating the part of the critical path to commercialization that is not the strength of most researchers toiling in laboratories.
She knows what the founders dont know it just makes a perfect match, said Michael Dishowitz, portfolio manager at PCI Ventures, an arm of Penn that helps university start-ups find investors, recruit management, and get to market.
Since its formation about eight years ago, PCI has helped more than 150 companies secure more than $100 million in funding, said Dishowitz, who has a doctoratein bioengineering from Penn and spent several years studying the impact of cell-signaling pathways on orthopedic injury.
While calling PolyAurums technology cool and very transformative for treatment, Dishowitz also delivered a dose of reality about the rigors ahead, as health-care start-ups must navigate a course with no guarantees their products will lead to actual clinical implementation.
PolyAurum is one of 13 companies that entered Philadelphia Media Networks second annual Stellar StartUps competition in the health-care/life sciences category. A total of nine categories drew 88 applicants. The winners will be announced Sept. 12 at an event at the Franklin Institutes Fels Planetarium. (Details at http://www.philly.com/stellarstartups.)
A lot has to go right, all the planets and stars have to align for this to hit the market, Dishowitz said of PolyAurums commercial prospects.
Which is why the team behind any start-up is so essential to investors, he said, calling Travers interest in joining a company that has yet been unable to pay her (she has equity in PolyAurum) incredibly lucky.
Margo Reed
At the Nanomedicine and Molecular Imaging Lab at Penn Medicine are (front row, from left) Jay Dorsey, a radiation oncologist and a founder of PolyAurum; Debra Travers, CEO; and Andrew Tsourkas, another founder of PolyAurum; and (back row, from left) Michael Dishowitz, portfolio manager, PCI Ventures at Penn; and David Cormode, lab director and PolyAurum founder. (MARGO REED / Staff Photographer)
The only thing Travers corporate-heavy background lacked, he said, was raising money for a start-up. It doesnt worry him, Dishowitz said, citing Travers perseverance, no-quit attitude.
When youre out there raising money, youre going to hear no about 100, 150 times before you hear yes, Dishowitz said.
When it comes to pitching for PolyAurum, Travers has extra incentive.
I am working on a cancer therapeutic, which is very important to the 11-year cancer survivor in me, she said.
As for handling nos, shes had plenty of professional experience with that.
After spending 30-plus years in the drug and diagnostic industries, where it is hard to find women CEOs or board members, Travers said, Ive learned to ignore the negative voices.
When: 5:30-8:30 p.m. Tuesday, Sept. 12.
Where: Fels Planetarium, Franklin Institute, 222 N. 20th St., Philadelphia 19103
For more information: http://www.philly.com/stellarstartups
Published: July 28, 2017 3:01 AM EDT
We recently asked you to support our journalism. The response, in a word, is heartening. You have encouraged us in our mission to provide quality news and watchdog journalism. Some of you have even followed through with subscriptions, which is especially gratifying. Our role as an independent, fact-based news organization has never been clearer. And our promise to you is that we will always strive to provide indispensable journalism to our community. Subscriptions are available for home delivery of the print edition and for a digital replica viewable on your mobile device or computer. Subscriptions start as low as 25 per day.We're thankful for your support in every way.
Read the rest here:
Cancer survivor becomes a cancer fighter at a Philly start-up - Philly.com
- Advances in nanotechnology's fight against cancer - December 27th, 2013 [December 27th, 2013]
- Nanotechnology and Medicine - Nanomedicine and Disease ... - December 27th, 2013 [December 27th, 2013]
- Nanomedicine: Nanotechnology, Biology and Medicine - Official Site - December 27th, 2013 [December 27th, 2013]
- Nanomedicine Fact Sheet - December 27th, 2013 [December 27th, 2013]
- Nanomedicine, bionanotechnology | NanomedicineCenter.com - December 27th, 2013 [December 27th, 2013]
- Nanomedicine - Wikipedia, the free encyclopedia - December 27th, 2013 [December 27th, 2013]
- Nanomedicine for drug delivery - Srinivas Sridhar - Video - December 28th, 2013 [December 28th, 2013]
- IT-CRS 2013 workshop- Prof. Kevin Breackmans. Studying nanomedicine biobarriers - Video - December 30th, 2013 [December 30th, 2013]
- Nanotechnology in Medicine - UnderstandingNano - January 3rd, 2014 [January 3rd, 2014]
- Nanomedicine - Nanorobots in Medicine - UnderstandingNano - January 8th, 2014 [January 8th, 2014]
- Nanomedicine: Challenges and opportunities - Video - January 13th, 2014 [January 13th, 2014]
- Global Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019: Transparency Market Research - January 16th, 2014 [January 16th, 2014]
- NANOMEDICINE 1 - Video - January 17th, 2014 [January 17th, 2014]
- Researchers measure minuscule particles with 'tiny diving boards' - January 20th, 2014 [January 20th, 2014]
- High Unmet Needs in Therapeutics to Spur Growth in the Market for Nanotechnology in Drug Delivery, According to New ... - January 21st, 2014 [January 21st, 2014]
- Nanomedicine Market - Video - January 22nd, 2014 [January 22nd, 2014]
- Nanomedicine and human upper limit - Video - January 23rd, 2014 [January 23rd, 2014]
- Animated Nanomedicine movie - Video - February 2nd, 2014 [February 2nd, 2014]
- In Vitro Innovation: Testing Nanomedicine With Blood Cells On A Microchip - February 4th, 2014 [February 4th, 2014]
- Nanomedicine Market is Expected to Reach USD 177.60 Billion in 2019 - February 7th, 2014 [February 7th, 2014]
- NANOMEDICINE 4: AYDEN JACOB FROM UCSF - Video - February 7th, 2014 [February 7th, 2014]
- New Live-Cell Printing Technology Works Like Ancient Chinese Woodblocking - February 10th, 2014 [February 10th, 2014]
- NANOMEDICINE HANGOUT: ARSALAN SHABBIR MD - Video - February 14th, 2014 [February 14th, 2014]
- Using Mathematical Models to Understand Nanoscale Roughness Published by Dove Medical Press - February 17th, 2014 [February 17th, 2014]
- NTU and Northwestern University to set up $70 million nanomedicine research institute - February 20th, 2014 [February 20th, 2014]
- Interview with Medical Animator YURIY SVIDINENKO, about Nanotechnology Videos - Video - February 21st, 2014 [February 21st, 2014]
- TTU MSE nanomedicine lab NML 2013 f - Video - February 21st, 2014 [February 21st, 2014]
- Nanomedicine Vietsubtitles - Video - February 24th, 2014 [February 24th, 2014]
- Biochips for Better Cancer Therapy in NanoMedicine - Video - February 27th, 2014 [February 27th, 2014]
- 13 Nanomedicine Part 1 - Video - February 28th, 2014 [February 28th, 2014]
- 13 Nanomedicine part 2 - Video - February 28th, 2014 [February 28th, 2014]
- practicum nanomedicine pws Nicole en jordy - Video - March 6th, 2014 [March 6th, 2014]
- Nanomedicine, Detto tra Noi, 4 marzo 2014 - Video - March 6th, 2014 [March 6th, 2014]
- Brown Symposium XXXVI - Mauro Ferrari: "Nanomedicine and New Societal Horizons" - Video - March 9th, 2014 [March 9th, 2014]
- nanomedicine nanobiotix itele - Video - March 9th, 2014 [March 9th, 2014]
- NANOMEDICINE HANGOUT UNIVERSITY OF MIAMI ARSALAN SHABBIR MD - Video - March 16th, 2014 [March 16th, 2014]
- NANOMEDICINE HANGOUT1 - Video - March 21st, 2014 [March 21st, 2014]
- NANOMEDICINE HANGOUT - Video - March 21st, 2014 [March 21st, 2014]
- Ideas @Davos | Sonia Trigueros | Breakthroughs in Nanomedicine - Video - March 22nd, 2014 [March 22nd, 2014]
- Nanomedicine: towards development of patient-friendly drug-delivery systems - Video - March 23rd, 2014 [March 23rd, 2014]
- Nanomedicine Research - March 26th, 2014 [March 26th, 2014]
- Mining Genome Information for New Starting Points in Personalized Cancer Nanomedicine - Video - March 28th, 2014 [March 28th, 2014]
- Cancer Stem Cells as Preferential Target for Personalized Cancer Nanomedicine - Video - March 28th, 2014 [March 28th, 2014]
- Nanomedicine Against Malaria: Use of Poly-based Nanovectors for the Drug Delivery to Plasmodium - Video - March 29th, 2014 [March 29th, 2014]
- Panel - The Horizon of Nanomedicine and Targeted Drug Delivery - Video - March 29th, 2014 [March 29th, 2014]
- Panel - The Regulation Environment in Nanomedicine -- The Step to the Last Phase of Translation - Video - March 29th, 2014 [March 29th, 2014]
- Looking and Listening to Light from Liposome Nanostructures for Cancer Theranostics - Video - March 29th, 2014 [March 29th, 2014]
- Nanobiotix Selected to Present Data from NBTXR3 Clinical Trial at the 50th Annual Meeting of the American Society of ... - April 2nd, 2014 [April 2nd, 2014]
- Breakthroughs in Nanomedicine-A World Economic Forum Discussion-Ideas @Davos-WIRED - Video - April 4th, 2014 [April 4th, 2014]
- How IBM Is Using Nanotechnology To Tackle MRSA And HIV - April 5th, 2014 [April 5th, 2014]
- In latest generation of tiny biosensors, size isn't everything - April 14th, 2014 [April 14th, 2014]
- Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global ... - April 17th, 2014 [April 17th, 2014]
- doctors-hospital-surgery-AFprelax-210414.jpg - April 21st, 2014 [April 21st, 2014]
- Nanomedicine - Video - April 25th, 2014 [April 25th, 2014]
- Nanomedicine Presentation - Video - May 6th, 2014 [May 6th, 2014]
- Nanomedicine Promo - Video - May 6th, 2014 [May 6th, 2014]
- A skinful of nanoparticles starts to show - May 16th, 2014 [May 16th, 2014]
- nanomedicine edit1 - Video - May 17th, 2014 [May 17th, 2014]
- UB spinoff Nanobiotix working to bring cancer treatment to market - May 29th, 2014 [May 29th, 2014]
- DGAP-News: MagForce AG: MagForce AG to present at dbAccess German, Swiss & Austrian Conference 2014, held by Deutsche ... - June 2nd, 2014 [June 2nd, 2014]
- New nanomedicine by NTU and SERI scientists to bring relief to glaucoma patients - June 4th, 2014 [June 4th, 2014]
- New glaucoma treatment replaces the hassle of applying eyedrops daily - June 4th, 2014 [June 4th, 2014]
- Cancer Nanomedicine - The Cancer Nanomedicine Blog - June 5th, 2014 [June 5th, 2014]
- No More Eye Drops for Glaucoma - June 10th, 2014 [June 10th, 2014]
- Nanomatriaux 2014 - AGuIX in nanomedicine - Video - June 19th, 2014 [June 19th, 2014]
- Introduction to nanomedicine with emphasis on carrier-mediated drug targeting - Video - June 20th, 2014 [June 20th, 2014]
- Challenging the Old Order to Set New Frontiers in Nanoscience & Nanotechnology - June 21st, 2014 [June 21st, 2014]
- Welcome - Summer School on Nanomedicine and Innovation - Video - June 24th, 2014 [June 24th, 2014]
- Nanomedicine and IP - Video - June 25th, 2014 [June 25th, 2014]
- Global Nanomedicine Market: Industry Analysis, Size, Share,Growth, Trends, and Forecast 2013 - 2019 - June 30th, 2014 [June 30th, 2014]
- Scientists engineer nanoparticles to prevent bone cancer, strengthen bones - July 2nd, 2014 [July 2nd, 2014]
- Global Nanomedicine Market Projected to be Worth USD 177.60 billion by 2019 - July 4th, 2014 [July 4th, 2014]
- Nanobiotix revenue for the 2nd quarter of 2014 - July 11th, 2014 [July 11th, 2014]
- magforce - Using advanced nanomedicine for innovative therapies - Video - July 25th, 2014 [July 25th, 2014]
- Shelton firms products in the pipeline could end diseases - July 29th, 2014 [July 29th, 2014]
- In the Quest to Treat Intracerebral Hemorrhage, Nanomaterials Show Promise - July 31st, 2014 [July 31st, 2014]
- Researchers to track effects of revolutionary new medicines - August 8th, 2014 [August 8th, 2014]
- Nanomedicine & RA with Dr. Bottini - Video - August 8th, 2014 [August 8th, 2014]
- Cellular Surgeons: The New Era of Nanomedicine - Full Program - Video - August 8th, 2014 [August 8th, 2014]
- DGAP-News: MagForce AG: Successful final closing of a growth financing round for MagForce USA, Inc. under the lead of ... - August 9th, 2014 [August 9th, 2014]